Greenwich Wealth Management LLC Buys 176 Shares of Centene Co. (NYSE:CNC)

Greenwich Wealth Management LLC raised its stake in Centene Co. (NYSE:CNC) by 0.5% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 37,578 shares of the company’s stock after buying an additional 176 shares during the period. Greenwich Wealth Management LLC’s holdings in Centene were worth $2,789,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. Operose Advisors LLC bought a new position in shares of Centene in the 3rd quarter worth $25,000. Turtle Creek Wealth Advisors LLC purchased a new position in Centene in the 4th quarter worth $25,000. Coppell Advisory Solutions Corp. purchased a new position in Centene in the 4th quarter worth $25,000. OFI Invest Asset Management purchased a new position in Centene in the 3rd quarter worth $26,000. Finally, Riggs Asset Managment Co. Inc. purchased a new position in Centene in the 4th quarter worth $32,000. Institutional investors own 93.63% of the company’s stock.

Insider Buying and Selling

In related news, President Kenneth J. Fasola sold 12,000 shares of the business’s stock in a transaction dated Wednesday, February 7th. The shares were sold at an average price of $75.07, for a total transaction of $900,840.00. Following the sale, the president now owns 235,365 shares of the company’s stock, valued at $17,668,850.55. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In other news, President Kenneth J. Fasola sold 12,000 shares of the company’s stock in a transaction that occurred on Wednesday, February 7th. The shares were sold at an average price of $75.07, for a total value of $900,840.00. Following the transaction, the president now owns 235,365 shares in the company, valued at $17,668,850.55. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Lori Jean Robinson sold 10,000 shares of the company’s stock in a transaction that occurred on Tuesday, February 13th. The stock was sold at an average price of $77.41, for a total transaction of $774,100.00. Following the completion of the transaction, the director now owns 11,455 shares in the company, valued at approximately $886,731.55. The disclosure for this sale can be found here. 0.33% of the stock is currently owned by insiders.

Analyst Ratings Changes

A number of brokerages recently commented on CNC. Cantor Fitzgerald reiterated an “overweight” rating and issued a $90.00 target price on shares of Centene in a research report on Thursday, April 4th. Wells Fargo & Company lifted their target price on shares of Centene from $89.00 to $93.00 and gave the stock an “overweight” rating in a research report on Monday, April 15th. Barclays began coverage on shares of Centene in a research report on Wednesday, March 6th. They issued an “overweight” rating and a $101.00 price objective on the stock. Stephens restated an “equal weight” rating and issued a $85.00 price objective (down previously from $92.00) on shares of Centene in a research report on Thursday, March 21st. Finally, StockNews.com cut shares of Centene from a “strong-buy” rating to a “buy” rating in a research report on Thursday, March 28th. Five investment analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to data from MarketBeat, Centene presently has an average rating of “Moderate Buy” and an average target price of $85.38.

Centene Trading Up 1.9 %

Shares of CNC traded up $1.40 during trading hours on Friday, reaching $75.15. 2,686,979 shares of the company traded hands, compared to its average volume of 3,192,411. The company’s fifty day moving average price is $76.56 and its two-hundred day moving average price is $74.65. The company has a market capitalization of $40.20 billion, a price-to-earnings ratio of 15.31, a price-to-earnings-growth ratio of 0.93 and a beta of 0.38. The company has a quick ratio of 1.11, a current ratio of 1.11 and a debt-to-equity ratio of 0.68. Centene Co. has a 12 month low of $60.83 and a 12 month high of $81.42.

Centene (NYSE:CNC) last posted its quarterly earnings data on Tuesday, February 6th. The company reported $0.45 EPS for the quarter, topping the consensus estimate of $0.43 by $0.02. Centene had a net margin of 1.75% and a return on equity of 14.26%. The business had revenue of $39.46 billion for the quarter, compared to analyst estimates of $36.16 billion. During the same quarter in the previous year, the firm posted $0.86 earnings per share. Centene’s quarterly revenue was up 11.0% on a year-over-year basis. Equities research analysts predict that Centene Co. will post 6.75 earnings per share for the current fiscal year.

Centene Company Profile

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support.